Literature DB >> 13761727

Studies concerning the turnover of fibrinogen I-131 in the dog.

J H LEWIS, E E FERGUSON, C SCHOENFELD.   

Abstract

Entities:  

Keywords:  FIBRINOGEN/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13761727

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  9 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  TURNOVER OF 131-I-LABELLED FIBRINOGEN IN FEVER.

Authors:  E L REGOECZI; G E HENLEY; R C HOLLOWAY; A S MCFARLANE
Journal:  Br J Exp Pathol       Date:  1963-08

3.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

4.  IN VIVO BEHAVIOR OF I-FIBRINOGEN.

Authors:  A S McFarlane
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

5.  Symposium on Fibrinolysis.

Authors:  J L Stafford
Journal:  Proc R Soc Med       Date:  1963-05

Review 6.  Protein metabolism following injury.

Authors:  J W Davies
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

7.  Serum fibrin degradation products throughout normal pregnancy.

Authors:  D G Woodfield; S K Cole; A G Allan; J D Cash
Journal:  Br Med J       Date:  1968-12-14

8.  [Diagnostic and therapeutic problems in congenital afibrinogenemia].

Authors:  R Egbring; K Andrassy; H Egli; J Meyer-Lindenberg
Journal:  Blut       Date:  1971-04

9.  Significance of the rate of decrease in fibrinogen level after total hepatectomy in dogs.

Authors:  R B Rutherford; R M Hardaway
Journal:  Ann Surg       Date:  1966-01       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.